The World Summit Awards recognize those international projects best aligned with compliance with the United Nations ODS. More than 100 countries have participated, with more than 400 nominations. Of these, 131 social digital projects have been selected, focusing on digital content, user value, and social impact.

In a first-round, the WSA international jury selected the best solutions to nominate a SHORTLIST for the awards in December 2019.
Discover here the 15-20 projects in each WSA category that are using digital content to close the global gaps and make a beneficial impact on their communities.

mjn-neuro was already proud that our solution to help people with epilepsy was among the top 15 digital health solutions that help achieve ODS.

WSA named us GLOBAL CHAMPION in our category

In March 2020, just before the state of alarm caused by COVID, our CEO was in Vienna for the final awards. After presenting our project to an international jury, WSA named us GLOBAL CHAMPION in our category, as the best project in the world in the category of digital health and wellness.

The entire mjn-neuro team is proud to be recognized by the World Summit Awards as #GLOBALCHAMPION. We are very happy to explain how we can help people with #epilepsy and be recognized for the social impact of our project.

Leave a Reply

El usuario que cumplimenta la información requerida en el presente formulario declara estar legitimado para ello y se hace responsable exclusivo de la veracidad e integridad de los datos e información que introduce, exonerando expresamente a MJN NEUROSERVEIS de cualquier responsabilidad que pudiera generarse para esta entidad con ocasión de la información facilitada a través del presente formulario.

Sí, acepto

Save the date

The next Saturday 21st of November at 4 pm, you will be able to know first hand our product: mjn-SERAS.
mjn-SERAS is a healthcare product that sends a warning signal when the risk of epileptic seizures is high, to the affected person and their trusted contacts.

Sign up now!


    mjn-SERAS is a medical device with CE marking according to the European Directive 93/42/EEC and the Royal Decree RD. 1591/2009.
    Contraindications: Do not use the product if you suffer from an infection in the ear canal or if you suffer from a skin lesion in the vicinity of the product's area of influence.
    Considerations: This medical product works with an APP only on Android phones. The results tested are 96% sensitivity and 94% specificity.
    CPSP20103CAT.

    Save the date

    El próximo sábado 21 de noviembre a las 4 de la tarde, podrás conocer de primera mano nuestro producto: mjn-SERAS.
    mjn-SERAS es un producto sanitario que lanza una señal de aviso cuando el riesgo de crisis de epilepsia es elevado, a la persona afectada y a sus contactos de confianza.

    ¡Inscríbete!

      mjn-SERAS es un producto sanitario con marcado CE conforme a la Directiva Europea 93/42/EEC y el Real Decreto RD. 1591/2009.
      Contraindicaciones: No usar el producto en caso de padecer una infección en el canal auditivo o en caso de padecer una lesión cutánea en las proximidades del área de influencia del producto.
      Consideraciones: Este producto sanitario funciona con una APP solo en teléfonos Android. Los resultados testeados son 96% de sensibilidad y 94% de especificidad.
      CPSP20103CAT.